Introduction
This report analyzes the current and potential world markets for molecular diagnostics, including advances in the field. This report generally forecasts future growth to 2015. The report breaks down market forecasts by type of test and by geography. It indicates which companies have key products in the market place. It also analyzes key drivers of this market.
Scope of this research
- Explains how molecular diagnostics represents a business opportunity for the IVD industry
- Evaluates drivers and trends behind the growth of molecular diagnostics
- Reviews key challenges facing molecular diagnostic manufacturers and those companies looking to enter the market
- Analysis of markets by key types of testing, products, and by country; analysis showing the top products and opportunities.
- Profiles key players in the field, including established companies and growing companies with innovative technology.
Research and analysis highlights
Two important growth drivers in the clinical setting for molecular diagnostics include the need for new biomarker assays as well as for techniques that lower the cost per test, and which improve ease of use, data quality and turnaround time.
By far, most of the established market for molecular diagnostics lies in the North American region. The market is building in Europe, but is still at relatively an early stage in the rest of the world. Geographically, the US and European markets are the most advanced in terms of adoption of molecular testing and make up the majority of the market.
In the current market for HPV, only about 20% of women over the age of 30 are screened for HPV using DNA-based tests in conjunction with a standard Pap smear, which leaves a lot of room for market growth.
Key reasons to purchase this research
- Understand each market in terms of size as well as its future potential.
- Understand which key products are already in the market place for each market segment analyzed.
- Evaluates which segment future opportunities may lie for companies.
- Understand key issues & challenges facing molecular diagnostics makers & their component suppliers thus helping potential entrants review the issues
- Learn about possible products from recent market developments mentioned in the report.